Mishra Pranav, Albensi Benedict C, Fernyhough Paul
Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, University of Manitoba, Winnipeg, Canada; Department of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, University of Manitoba, Winnipeg, Canada; Department of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Department of Pharmaceutical Sciences, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
Mol Cell Neurosci. 2025 Jun;133:104008. doi: 10.1016/j.mcn.2025.104008. Epub 2025 Mar 29.
Adult rat dorsal root ganglion (DRG) sensory neurons express estrogen receptors (ERs) α and β. Estrogen regulates multiple aspects of the nervous system including development, survival, and axonal outgrowth of DRG neurons. While previous studies have established estrogen's neuroprotective role in these neurons, the specific ER subtypes and downstream signaling pathways mediating these effects remain poorly defined. The objective of our study was to investigate the effects of 17 beta-estradiol (E2) on mitochondrial function and axonal regeneration of cultured DRG neurons and explore the pathways by which E2 acts. We observed that E2 treatment upregulated the levels of phosphorylated AMP-activated protein kinase (AMPK). E2 also increased the levels of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) and activating transcription factor 3 (ATF3), which are proteins involved in mitochondrial biogenesis and axonal regeneration. The Seahorse assay showed that E2 elevated basal respiration in cultured DRG neurons. Additionally, E2 treatment for 24 h significantly increased total neurite outgrowth of DRG neurons. Pharmacological inhibition of AMPK using Compound C inhibited E2-mediated increases in ATF3 expression and neurite outgrowth. The Ca/calmodulin-dependent protein kinase kinase β (CaMKKβ) inhibitor STO-609 blocked E2-mediated AMPK activation. Furthermore, we assessed whether these effects were mediated by ERα or ERβ by using the ERα selective agonist propyl pyrazole triol (PPT) and ERβ selective agonist diarylpropionitrile (DPN). PPT upregulated phosphorylated AMPK levels and increased total neurite outgrowth, whereas DPN was ineffective. The results demonstrate that E2 acts through ERα to promote neurite outgrowth via a pathway involving activation of CaMKKβ/AMPK in adult DRG neurons. Our findings identify ERα-mediated AMPK activation as a therapeutic target for enhancing neuronal regeneration and mitochondrial function in neurodegenerative disorders.
成年大鼠背根神经节(DRG)感觉神经元表达雌激素受体(ERs)α和β。雌激素调节神经系统的多个方面,包括DRG神经元的发育、存活和轴突生长。虽然先前的研究已经确立了雌激素在这些神经元中的神经保护作用,但介导这些作用的特定ER亚型和下游信号通路仍不清楚。我们研究的目的是探讨17β-雌二醇(E2)对培养的DRG神经元线粒体功能和轴突再生的影响,并探索E2发挥作用的途径。我们观察到E2处理上调了磷酸化AMP激活蛋白激酶(AMPK)的水平。E2还增加了过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)和激活转录因子3(ATF3)的水平,这些蛋白参与线粒体生物发生和轴突再生。海马实验表明,E2提高了培养的DRG神经元的基础呼吸。此外,E2处理24小时显著增加了DRG神经元的总神经突生长。使用化合物C对AMPK进行药理学抑制可抑制E2介导的ATF3表达增加和神经突生长。钙/钙调蛋白依赖性蛋白激酶激酶β(CaMKKβ)抑制剂STO-609阻断了E2介导的AMPK激活。此外,我们使用ERα选择性激动剂丙基吡唑三醇(PPT)和ERβ选择性激动剂二芳基丙腈(DPN)评估了这些作用是否由ERα或ERβ介导。PPT上调了磷酸化AMPK水平并增加了总神经突生长,而DPN则无效。结果表明,E2通过ERα作用,通过涉及激活成年DRG神经元中CaMKKβ/AMPK的途径促进神经突生长。我们的研究结果确定ERα介导的AMPK激活是增强神经退行性疾病中神经元再生和线粒体功能的治疗靶点。